-
Something wrong with this record ?
Serum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: a pilot study
M. Zemanová, B. Staňková, Z. Ušiakova, E. Tvrzická, A. Pazdro, L. Petruželka, M. Zeman,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT12331
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
PubMed Central
from 2011
Europe PubMed Central
from 2011
Open Access Digital Library
from 2011-01-01
PubMed
25408239
DOI
10.12659/msm.891088
Knihovny.cz E-resources
- MeSH
- Adiponectin blood MeSH
- Survival Analysis MeSH
- Chemoradiotherapy * MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Multivariate Analysis MeSH
- Esophageal Neoplasms blood surgery therapy MeSH
- Pilot Projects MeSH
- Preoperative Care * MeSH
- Proportional Hazards Models MeSH
- Aged MeSH
- Carcinoma, Squamous Cell blood surgery therapy MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: The convergence of nutritional, genetic, and inflammatory factors plays a significant role in the pathophysiology of squamous cell esophageal cancer (SCEC). The parameters of inflammation, indices of nutritional status, and adipocyte-derived hormones such as leptin, adiponectin, and resistin have been shown to be prognostic factors in some gastrointestinal and pancreatic cancers. MATERIAL/METHODS: Forty-two patients with SCEC were subjected to a multimodal regimen of concurrent neoadjuvant chemoradiotherapy (CRT) followed by surgery. We retrospectively analyzed the impact of pretreatment values of serum leptin, adiponectin, resistin, soluble leptin receptor, C-reactive protein, TNF alpha, leukocytes, and indices of nutritional status (BMI, plasma total protein, albumin, cholesterol, and triacylglycerols) on overall survival (OS). RESULTS: Univariate analysis revealed significant a negative correlation between OS and serum adiponectin (p=0.027), and a positive relationship was found between serum albumin (p=0.002), cholesterol (p=0.049) level, and OS. In multivariate analysis, only the trend (p=0.086) for negative serum adiponectin association with the OS was observed. CONCLUSIONS: In men with SCEC treated by neoadjuvant concurrent CRT and esophagectomy, high pretreatment level of serum adiponectin was associated with shorter OS while the serum albumin and cholesterol were associated with longer OS.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15022928
- 003
- CZ-PrNML
- 005
- 20181213110443.0
- 007
- ta
- 008
- 150709s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.12659/MSM.891088 $2 doi
- 035 __
- $a (PubMed)25408239
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Zemanová, Milada $u Clinic of Oncology, 1st Faculty of Medicine of Charles University in Prague and General University Hospital, Prague, Czech Republic. $7 xx0060597
- 245 10
- $a Serum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: a pilot study / $c M. Zemanová, B. Staňková, Z. Ušiakova, E. Tvrzická, A. Pazdro, L. Petruželka, M. Zeman,
- 520 9_
- $a BACKGROUND: The convergence of nutritional, genetic, and inflammatory factors plays a significant role in the pathophysiology of squamous cell esophageal cancer (SCEC). The parameters of inflammation, indices of nutritional status, and adipocyte-derived hormones such as leptin, adiponectin, and resistin have been shown to be prognostic factors in some gastrointestinal and pancreatic cancers. MATERIAL/METHODS: Forty-two patients with SCEC were subjected to a multimodal regimen of concurrent neoadjuvant chemoradiotherapy (CRT) followed by surgery. We retrospectively analyzed the impact of pretreatment values of serum leptin, adiponectin, resistin, soluble leptin receptor, C-reactive protein, TNF alpha, leukocytes, and indices of nutritional status (BMI, plasma total protein, albumin, cholesterol, and triacylglycerols) on overall survival (OS). RESULTS: Univariate analysis revealed significant a negative correlation between OS and serum adiponectin (p=0.027), and a positive relationship was found between serum albumin (p=0.002), cholesterol (p=0.049) level, and OS. In multivariate analysis, only the trend (p=0.086) for negative serum adiponectin association with the OS was observed. CONCLUSIONS: In men with SCEC treated by neoadjuvant concurrent CRT and esophagectomy, high pretreatment level of serum adiponectin was associated with shorter OS while the serum albumin and cholesterol were associated with longer OS.
- 650 _2
- $a adiponektin $x krev $7 D052242
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a spinocelulární karcinom $x krev $x chirurgie $x terapie $7 D002294
- 650 12
- $a chemoradioterapie $7 D059248
- 650 _2
- $a nádory jícnu $x krev $x chirurgie $x terapie $7 D004938
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a multivariační analýza $7 D015999
- 650 _2
- $a pilotní projekty $7 D010865
- 650 12
- $a předoperační péče $7 D011300
- 650 _2
- $a proporcionální rizikové modely $7 D016016
- 650 _2
- $a analýza přežití $7 D016019
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Staňková, Barbora $u 4th Department of Internal Medicine, 1st Faculty of Medicine of Charles University in Prague and General University Hospital, Prague, Czech Republic. $7 xx0133413
- 700 1_
- $a Bielčíková, Zuzana $u Clinic of Oncology, 1st Faculty of Medicine of Charles University in Prague and General University Hospital, Prague, Czech Republic. $7 xx0225233
- 700 1_
- $a Tvrzická, Eva $u 4th Department of Internal Medicine, 1st Faculty of Medicine of Charles University in Prague and General University Hospital, Prague, Czech Republic. $7 xx0076496
- 700 1_
- $a Pazdro, Alexandr $u 3rd Clinic of Surgery, 1st Faculty of Medicine of Charles University in Prague and General University Hospital, Prague, Czech Republic. $7 xx0093307
- 700 1_
- $a Petruželka, Luboš, $u Clinic of Oncology, 1st Faculty of Medicine of Charles University in Prague and General University Hospital, Prague, Czech Republic. $d 1952- $7 jn19990209650
- 700 1_
- $a Zeman, Miroslav, $u 4rd Department of Internal Medicine, 1st Faculty of Medicine of Charles University in Prague and General University Hospital, Prague, Czech Republic. $d 1950- $7 skuk0006053
- 773 0_
- $w MED00003251 $t Medical science monitor international medical journal of experimental and clinical research $x 1643-3750 $g Roč. 20, č. - (2014), s. 2351-2357
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25408239 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20181213110608 $b ABA008
- 999 __
- $a ok $b bmc $g 1083267 $s 905921
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 20 $c - $d 2351-2357 $i 1643-3750 $m Medical Science Monitor $n Med Sci Monit $x MED00003251
- GRA __
- $a NT12331 $p MZ0
- LZP __
- $a Pubmed-20150709